Skip to main content
. 2017 Jul 27;11(1):71–76. doi: 10.1111/cts.12493

Table 2.

Percent of patients with an actionablea result based on CPIC guidelines

CPIC guideline Actionable result, n (%)
CYP2C9‐Phenytoin 30 (30.3)
CYP2C19‐Citalopram/Escitalopram 43 (43.4)
CYP2C19‐Clopidogrel 21 (21.2)
CYP2C19‐Sertraline 2 (2)
CYP2C19‐Tricyclic antidepressants 43 (43.4)
CYP2C19‐Voriconazole 43 (43.4)
CYP2C9/VKORC1‐Warfarin 39 (39.4)
a

Actionable is defined by whether a change in drug therapy may be recommended based on the genotype result.